Persistence of superficial basal cell carcinoma during pembrolizumab treatment for metastatic melanoma

European Journal of Dermatology ◽

10.1684/ejd.2020.3958 ◽

2021 ◽

Vol 31 (1) ◽

pp. 99-100

Author(s):

Irene Russo ◽

Angela Filoni ◽

Mauro Alaibac

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Metastatic Melanoma ◽

Superficial Basal Cell Carcinoma

Download Full-text

Faculty Opinions recommendation of Thickness of superficial basal cell carcinoma (sBCC) predicts imiquimod efficacy: a proposal for a thickness-based definition of sBCC.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718004289.793478419 ◽

2013 ◽

Author(s):

Iris Zalaudek ◽

Aimilios Lallas

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Superficial Basal Cell Carcinoma ◽

Download Full-text

Faculty Opinions recommendation of Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718016210.793479146 ◽

2013 ◽

Author(s):

Melvin Chiu

Keyword(s):

Photodynamic Therapy ◽

Randomised Controlled Trial ◽

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Controlled Trial ◽

Topical Imiquimod ◽

Superficial Basal Cell Carcinoma ◽

Randomised Controlled ◽

Download Full-text

Faculty Opinions recommendation of A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718844198.793505941 ◽

2015 ◽

Author(s):

John Carucci

Keyword(s):

Photodynamic Therapy ◽

Clinical Study ◽

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Methyl Aminolevulinate ◽

Superficial Basal Cell Carcinoma

Download Full-text

Response to ‘Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial: a critical appraisal’

British Journal of Dermatology ◽

10.1111/bjd.13565 ◽

2015 ◽

Vol 172 (1) ◽

pp. 11-12

Author(s):

A. Arits ◽

P. Nelemans ◽

N. Kelleners-Smeets

Keyword(s):

Photodynamic Therapy ◽

Randomised Controlled Trial ◽

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Critical Appraisal ◽

Controlled Trial ◽

Superficial Basal Cell Carcinoma ◽

Randomised Controlled ◽

Download Full-text

Confirmation of histological clearance of superficial basal cell carcinoma with multiple serial sectioning and Mohs' micrographic surgery following treatment with imiquimod 5% cream

Journal of Dermatological Treatment ◽

10.1080/09546630701759603 ◽

2008 ◽

Vol 19 (3) ◽

pp. 156-158 ◽

Author(s):

Francesca I. Ezughah ◽

Andrew G. Affleck ◽

Alan Evans ◽

Sally H. Ibbotson ◽

Colin J. Fleming

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Mohs Micrographic Surgery ◽

Serial Sectioning ◽

Micrographic Surgery ◽

Superficial Basal Cell Carcinoma

Download Full-text

Photodynamic therapy vs. topical imiquimod for treatment of superficial basal cell carcinoma: a subgroup analysis within a noninferiority randomized controlled trial

British Journal of Dermatology ◽

10.1111/bjd.13299 ◽

2014 ◽

Vol 172 (3) ◽

pp. 739-745 ◽

Author(s):

M.H. Roozeboom ◽

P.J. Nelemans ◽

K. Mosterd ◽

P.M. Steijlen ◽

A.H.M.M. Arits ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Photodynamic Therapy ◽

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Subgroup Analysis ◽

Controlled Trial ◽

Randomized Controlled ◽

Topical Imiquimod ◽

Superficial Basal Cell Carcinoma

Download Full-text

Dermoscopic Monitoring of Tazarotene Treatment of Superficial Basal Cell Carcinoma

Dermatologic Surgery ◽

10.1097/00042728-200502000-00018 ◽

2005 ◽

Vol 31 (2) ◽

pp. 217-220 ◽

Author(s):

KETTY PERIS ◽

ANGELA FERRARI ◽

MARIA CONCETTA FARGNOLI ◽

DOMENICO PICCOLO ◽

SERGIO CHIMENTI

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Superficial Basal Cell Carcinoma

Download Full-text

Superficial Basal Cell Carcinoma Treated with Two Cycles of Ingenol Mebutate Gel 0.015%

Annals of Dermatology ◽

10.5021/ad.2016.28.6.796 ◽

2016 ◽

Vol 28 (6) ◽

pp. 796 ◽

Author(s):

Yu Seok Jung ◽

Ji Hae Lee ◽

Jung Min Bae ◽

Gyong Moon Kim

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Ingenol Mebutate ◽

Superficial Basal Cell Carcinoma

Download Full-text

Efficacy of imiquimod 5% cream in the treatment of superficial basal cell carcinoma

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2003.10.433 ◽

2004 ◽

Vol 50 (3) ◽

pp. P127

Author(s):

John Geisse ◽

Ivor Caro ◽

Jane Lindholm ◽

Loren Golitz

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Superficial Basal Cell Carcinoma

Download Full-text

A review of emerging and non-US FDA-approved topical agents for the treatment of basal cell carcinoma

Future Oncology ◽

10.2217/fon-2020-1147 ◽

2021 ◽

Author(s):

Natalie Kash ◽

Sirunya Silapunt

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Gold Standard ◽

Treatment Options ◽

Tumor Characteristics ◽

Tumor Clearance ◽

Superficial Basal Cell Carcinoma ◽

Us Fda ◽

Although surgical therapy continues to be the gold standard for the treatment of basal cell carcinoma given high cure rates and the ability to histologically confirm tumor clearance, there are a number of nonsurgical treatment options that may be considered based on individual tumor characteristics, functional and cosmetic considerations, patient comorbidities and patient preference. Topical 5-fluorouracil 5% cream and imiquimod 5% cream have been US FDA-approved for the treatment of superficial basal cell carcinoma. Additionally, a number of new and emerging topical agents and techniques have been described for the treatment of basal cell carcinoma and will be reviewed herein.

Download Full-text